Projected Income Statement: Reckitt Benckiser Group plc

Forecast Balance Sheet: Reckitt Benckiser Group plc

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt 1 8,954 8,378 7,984 7,290 7,914 8,013 7,738 7,465
Change - -6.43% -4.7% -8.69% 8.56% 1.25% -3.43% -3.53%
Announcement Date 2/24/21 2/17/22 3/1/23 2/28/24 3/6/25 - - -
1GBP in Million
Estimates

Cash Flow Forecast: Reckitt Benckiser Group plc

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
CAPEX 1 486 450 362 449 465 507 515.1 549.5
Change - -7.41% -19.56% 24.03% 3.56% 9.03% 1.6% 6.67%
Free Cash Flow (FCF) 1 3,052 1,258 2,031 2,258 2,232 1,835 2,378 2,508
Change - -58.78% 61.45% 11.18% -1.15% -17.77% 29.58% 5.44%
Announcement Date 2/24/21 2/17/22 3/1/23 2/28/24 3/6/25 - - -
1GBP in Million
Estimates

Forecast Financial Ratios: Reckitt Benckiser Group plc

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027

Profitability

        
EBITDA Margin (%) 26.96% 24.94% 27.99% 26.13% 27.6% 27.78% 28.1% 28.51%
EBIT Margin (%) 23.59% 21.74% 23.79% 23.09% 24.53% 24.7% 25% 25.22%
EBT Margin (%) 13.39% -1.96% 21.22% 16.44% 14.85% 19.4% 19.88% 23.27%
Net margin (%) 8.13% -0.24% 16.12% 11.25% 10.06% 13.89% 15.79% 16.62%
FCF margin (%) 21.81% 9.51% 14.05% 15.46% 15.75% 12.92% 16.2% 16.47%
FCF / Net Income (%) 268.43% -3,931.25% 87.17% 137.43% 156.52% 93.05% 102.56% 99.07%

Profitability

        
ROA 7.36% 7.07% 8.37% 5.88% 5.44% 8.96% 9.6% 9.95%
ROE 25.26% 24.94% 27.67% 18.3% 18.83% 35.21% 35.98% 37.43%

Financial Health

        
Leverage (Debt/EBITDA) 2.37x 2.54x 1.97x 1.91x 2.02x 2.03x 1.88x 1.72x
Debt / Free cash flow 2.93x 6.66x 3.93x 3.23x 3.55x 4.37x 3.25x 2.98x

Capital Intensity

        
CAPEX / Current Assets (%) 3.47% 3.4% 2.5% 3.07% 3.28% 3.57% 3.51% 3.61%
CAPEX / EBITDA (%) 12.88% 13.64% 8.95% 11.76% 11.89% 12.85% 12.48% 12.66%
CAPEX / FCF (%) 15.92% 35.77% 17.82% 19.88% 20.83% 27.62% 21.66% 21.91%

Items per share

        
Cash flow per share 1 4.929 2.378 3.341 3.67 3.822 3.874 4.156 4.65
Change - -51.75% 40.49% 9.85% 4.14% 1.37% 7.26% 11.9%
Dividend per Share 1 1.746 1.746 1.833 1.925 2.021 2.089 2.207 2.323
Change - 0% 4.98% 5.02% 4.99% 3.38% 5.63% 5.28%
Book Value Per Share 1 12.77 10.37 13.2 11.79 9.565 9.974 10.66 11.14
Change - -18.83% 27.35% -10.71% -18.86% 4.28% 6.92% 4.45%
EPS 1 1.663 -0.045 3.247 2.287 2.032 2.917 3.344 3.904
Change - -102.71% 7,315.56% -29.57% -11.15% 43.57% 14.63% 16.73%
Nbr of stocks (in thousands) 712,054 714,366 715,728 713,972 686,622 679,921 679,921 679,921
Announcement Date 2/24/21 2/17/22 3/1/23 2/28/24 3/6/25 - - -
1GBP
Estimates
2025 *2026 *
P/E ratio 17.5x 15.2x
PBR 5.11x 4.78x
EV / Sales 3x 2.89x
Yield 4.1% 4.33%
More valuation ratios * Estimated data

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Trading Rating
Investor Rating
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
50.96GBP
Average target price
58.36GBP
Spread / Average Target
+14.53%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. RB. Stock
  4. Financials Reckitt Benckiser Group plc